| Characteristics | n (CLT+) | n (CLT−) | p value |
| Gender |
|
|
|
| Male | 7 | 24 |
|
| Female | 63 | 59 |
|
| Age at diagnosis (years) |
|
|
|
| <45 | 46 | 52 |
|
| ≥45 | 24 | 31 |
|
| Histopathologc type |
|
|
|
| Well differentiated types | 64 | 76 |
|
| Poor prognostic types* | 6 | 7 |
|
| T stage |
|
|
|
| T1a | 33 | 44 |
|
| T1b | 30 | 28 |
|
| T2 | 2 | 8 |
|
| T3 | 3 | 5 |
|
| N stage |
|
|
|
| N0 | 35 | 57 |
|
| N1a | 23 | 38 |
|
| N1b | 9 | 14 |
|
| Number of LN in CLND material (mean ± SD) | 12 (8 - 16.25) | 7.5 (4 - 13) | <0.001 |
| Metastatic LN ratio (%) (mean ± SD) | 16.8 ± 12.2 | 46.4 ± 27.5 | <0.001 |